Drugmakers vulnerable if U.S. health law revoked – Reuters UK
Full repeal of the law could prompt a short-term rally of 3 percent to 5 percent for drugmakers' shares as investors account for the annulment of taxes and a delay in generic competition for profitable biotechnology medicines, said Michael ...
Subscribe to LegalLaw247.Com Newsletter